This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Some of the factors that influence HbA1c (glycosylated haemoglobin) and its measurement

Authoring team

Some of the factors that influence HbA1c and its measurement

  • 1. Erythropoiesis
    • Increased HbA1c: iron deficiency, vitamin B12 deficiency, decreased erythropoiesis

    • Decreased HbA1c: administration of erythropoietin, iron, vitamin B12, reticulocytosis, chronic liver disease

  • 2. Altered Haemoglobin
    • Genetic or chemical alterations in haemoglobin: haemoglobinopathies, HbF, methaemoglobin, may increase or decrease HbA1c

  • 3. Glycation
    • Increased HbA1c: alcoholism, chronic renal failure, decreased intraerythrocyte pH.
    • Decreased HbA1c: aspirin, vitamin C and E, certain haemoglobinopathies, increased intra-erythrocyte pH
    • Variable HbA1c: genetic determinants

  • 4. Erythrocyte destruction
    • Increased HbA1c: increased erythrocyte life span: Splenectomy

    • Decreased HbA1c: decreased erythrocyte life span: haemoglobinopathies, splenomegaly, rheumatoid arthritis or drugs such as antiretrovirals, ribavirin and dapsone

  • 5. Assays
    • Increased HbA1c: hyperbilirubinaemia, carbamylated haemoglobin, alcoholism, large doses of aspirin, chronic opiate use

    • Variable HbA1c: haemoglobinopathies

    • Decreased HbA1c: hypertriglyceridaemia

* Some of the above interfering factors are 'invisible' in certain of the available assays

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.